Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
3-(1,3,2-Dioxaborinan-2-yl)pyridine → tert-butyl 4-{[4-amino-2-ethoxymethyl-7-(pyridin-3-yl)-1H-imidazo[4,5-c]quinolin-1-yl]methyl}piperidine-1-carboxylate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 3-(1,3,2-Dioxaborinan-2-yl)pyridine | HCID 4198005 | — |
| 반응물 | Tert-butyl 4-[(4-amino-7-bromo-2-ethoxymethyl-1h-imidazo[4,5-c]quinolin-1-yl)methyl]piperidine-1-carboxylate | HCID 21984399 | — |
| 생성물 | tert-butyl 4-{[4-amino-2-ethoxymethyl-7-(pyridin-3-yl)-1H-imidazo[4,5-c]quinolin-1-yl]methyl}piperidine-1-carboxylate | HCID 21984389 | 85.4% |
반응 단계
tert-Butyl 4-[(4-amino-7-bromo-2-ethoxymethyl-1H-imidazo[4,5-c]quinolin-1-yl)methyl]piperidine-1-carboxylate (12.79 g, 24.67 mmol) and pyrdine-3-boronic acid 1,3-propanediol cyclic ester (4.42 g, 27.14 mmol) were coupled according to the method described in Examples 118–121. The work-up procedure described in Part F of Examples 125–135 was followed. The crude product was recrystallized twice from ethyl acetate to provide 10.89 g of tert-butyl 4-{[4-amino-2-ethoxymethyl-7-(pyridin-3-yl)-1H-imidazo[4,5-c]quinolin-1-yl]methyl}piperidine-1-carboxylate as an off-white solid, mp 197–198° C.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07091214B2 |
| 출처 데이터셋 | uspto-grants-2006_08 |
| ORD ID | ord-04d591006e5b432d8b0818bceb09fc67 |
| 출처 메모 | uspto-grants-2006_08 |